Korean competitors challenge Pfizer's leadership in amlodipine
Published: 2004-11-02 07:00:00
Updated: 2004-11-02 07:00:00
Korea's major pharmaceutical firms are racing to increase their market share in the domestic amlodipine market, prompting speculation that Pfizer Korea, a Korean unit of a multinational pharmaceutical firm, may face an uphill battle in the years ahead.
Another factor is that local large hospit...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
